VERSARIEN PLC

Legal Proceedings Report • Sep 10, 2025

National Storage Mechanism | Additional information

RNS Number : 8217Y

Versarien PLC

10 September 2025

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN

10 September 2025

Versarien plc

("Versarien", the "Company" or the "Group")

Corporate Update

Versarien plc (AIM: VRS), the advanced engineering materials group, provides a further update on its restructuring process.

As previously announced, the Company is in the process of conducting an accelerated sale of the Group's assets consisting of Versarien's patent portfolio and its shareholdings in Total Carbide Limited and Gnanomat SL. As announced on 29 August 2025, Versarien Graphene Limited is in administration and Cambridge Graphene Limited and 2-DTech Limited are in voluntary liquidation proceedings.

A range of offers have now been received from a number of interested parties, which the Board is currently evaluating. Until legal agreements are signed there is no certainty of the outcome. As previously announced, the Company has taken actions to conserve cash such that its cash runway is now forecast, but not certain, to last until the end of September 2025.  

Further announcements will be made in due course as appropriate.

For further information please contact:

Versarien Stephen Hodge, Chief Executive Officer Chris Leigh, Chief Financial Officer	c/o IFC
SP Angel Corporate Finance (Nominated Adviser and Broker) Matthew Johnson, Adam Cowl	+44 (0)20 3470 0470
IFC Advisory Limited (Financial PR and Investor Relations) Tim Metcalfe, Zach Cohen	+44 (0)20 3934 6630

For further information please see:  http://www.versarien.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

UPDLMMBTMTIBBJA